Remove 2014 Remove Doctors Remove Patients Remove Safety
article thumbnail

Relief for Amylyx as FDA clears controversial ALS drug Relyvrio

pharmaphorum

Patient organisations have been celebrating the FDA approval yesterday of Amylyx’ amyotrophic lateral sclerosis (ALS) therapy Relyvrio, after not one but two advisory committee meetings that arrived at different conclusions about the drug.

FDA 82
article thumbnail

NICE says statins should be used more widely in NHS

pharmaphorum

Cholesterol-lowering statin drugs could be available to millions more patients in the UK, if new recommendations from health technology assessment (HTA) organisation NICE are implemented. Current modelling suggests 40 avoided cardiovascular events in patients with risk between 10% and 20%, and 70 for those above the 20% threshold.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Securing every dose with an edible security technology for safe medicines

European Pharmaceutical Review

FAKE MEDICINES are not a new problem, and pose a tremendous threat to patient safety and public health in society regardless of a country’s economic status. Unfortunately, such a chain of custody is not intended to provide patients with the ability to verify their own medicines. 2019; Available from: [link].

article thumbnail

Private Patient Advocacy: Educating Patients To Be Their Own Advocates With Antra Boyd And Karen DiMarco

Evolve Your Success

In a world of medical and health jargon, it can be difficult for patients to understand the kind of care they are getting. Sometimes, beyond the language, it is in the way health professionals communicate to the patient and their families as well as to each other. They are also patient advocates from their experience in nursing.

article thumbnail

The benefits of mass spectrometry for expediting biologics to patients

European Pharmaceutical Review

The growing presence of these unintended amino acid sequences in recombinant proteins is a top concern for regulators and drug manufacturers due to the ability of these mutations to cause higher order structural problems, potentially affecting efficacy and safety. While SVs are typically present at less than 0.1 2020; 12(1): 1791399.

article thumbnail

Medical Sales In Sterile Processing And Infection Prevention With Mark Copeland

Evolve Your Success

Mark discusses the role of value analysis in improving their products and services, allowing them to properly address the ever-changing and specific needs of patients. I find reps, doctors, and directors. The way these doctors make decisions and the way these things occur, for whatever reason, it fascinated me. I did well there.

article thumbnail

Driving Provider Engagement in Value-Based Care

Clarify Health

The challenges are universal in that we still need to get to a place where providers look at this as a partnership where we all come together for the benefit of the patient. Everything is headbutting, and it’s a hard thing for both sides to come together and say, “Yes, but now we got to focus on the patient.”